Trajenta Duo Contraindications

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Contraindications

Hypersensitivity to active ingredients linagliptin and/or metformin hydrochloride or to any of the excipients; Any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis); Diabetic pre-coma; Severe renal failure (CrCl <30 mL/min or eGFR <30 ml/min/1.73m² ); Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock, intravascular administration of iodinated contrast agents (see Precautions); Disease which may cause tissue hypoxia (especially acute disease, or worsening of chronic disease) such as: decompensated heart failure, cardiac or respiratory failure, recent myocardial infarction, shock; Hepatic impairment; Acute alcohol intoxication; Alcoholism.

Trajenta Duo Contraindications

linagliptin + metformin

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH